How much is Frontier Medicines worth in 2026?

Frontier Medicines has a current valuation of N/A based on their Later Stage VC (Series C) round and secondary market data.

How much funding has Frontier Medicines raised?

Frontier Medicines has raised N/A in total funding across 1 funding rounds.

Frontier Medicines

Drug Discovery

Frontier Medicines valuation and funding history | Last updated: February 26, 2024 | 1 funding rounds

Current Valuation

N/A

As of February 26, 2024

Total Funding Raised

N/A

Across 1 round

Last Round

Later Stage VC (Series C)

$100.0M

Last Funding

Feb 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
February 26, 2024	Later Stage VC (Series C)	$100.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Frontier Medicines is currently valued at N/A as of February 26, 2024.

Track Frontier Medicines Valuation Updates

Get notified when Frontier Medicines raises new funding or valuation changes

Explore More Data

Detailed analysis for Frontier Medicines

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Frontier Medicines's valuation history, funding rounds, and growth metrics.

No credit card required

What is Frontier Medicines Worth in 2026?

Frontier Medicines is a leading private company in the Drug Discovery sector. Track Frontier Medicines's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Frontier Medicines Valuation is Determined

Private company valuations like Frontier Medicines's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.